PortfoliosLab logo
RES vs. BTCY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between RES and BTCY is 0.31, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

RES vs. BTCY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in RPC, Inc. (RES) and Biotricity, Inc. (BTCY). The values are adjusted to include any dividend payments, if applicable.

-100.00%-90.00%-80.00%-70.00%-60.00%-50.00%-40.00%December2025FebruaryMarchAprilMay
-60.93%
-96.73%
RES
BTCY

Key characteristics

Sharpe Ratio

RES:

-0.60

BTCY:

-0.32

Sortino Ratio

RES:

-0.63

BTCY:

0.57

Omega Ratio

RES:

0.92

BTCY:

1.06

Calmar Ratio

RES:

-0.34

BTCY:

-0.59

Martin Ratio

RES:

-1.46

BTCY:

-0.95

Ulcer Index

RES:

19.29%

BTCY:

61.34%

Daily Std Dev

RES:

49.21%

BTCY:

179.29%

Max Drawdown

RES:

-92.34%

BTCY:

-99.67%

Current Drawdown

RES:

-80.33%

BTCY:

-99.14%

Fundamentals

Market Cap

RES:

$1.11B

BTCY:

$12.26M

EPS

RES:

$0.36

BTCY:

-$1.61

PEG Ratio

RES:

-2.73

BTCY:

0.00

PS Ratio

RES:

0.81

BTCY:

0.90

PB Ratio

RES:

1.02

BTCY:

33.02

Total Revenue (TTM)

RES:

$1.37B

BTCY:

$10.09M

Gross Profit (TTM)

RES:

$227.92M

BTCY:

$7.59M

EBITDA (TTM)

RES:

$232.04M

BTCY:

-$2.33M

Returns By Period

In the year-to-date period, RES achieves a -19.31% return, which is significantly lower than BTCY's 79.37% return.


RES

YTD

-19.31%

1M

10.70%

6M

-22.07%

1Y

-27.65%

5Y*

8.45%

10Y*

-9.72%

BTCY

YTD

79.37%

1M

36.79%

6M

44.39%

1Y

-57.22%

5Y*

-40.61%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

RES vs. BTCY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RES
The Risk-Adjusted Performance Rank of RES is 2020
Overall Rank
The Sharpe Ratio Rank of RES is 1818
Sharpe Ratio Rank
The Sortino Ratio Rank of RES is 2121
Sortino Ratio Rank
The Omega Ratio Rank of RES is 2121
Omega Ratio Rank
The Calmar Ratio Rank of RES is 3030
Calmar Ratio Rank
The Martin Ratio Rank of RES is 88
Martin Ratio Rank

BTCY
The Risk-Adjusted Performance Rank of BTCY is 3737
Overall Rank
The Sharpe Ratio Rank of BTCY is 3434
Sharpe Ratio Rank
The Sortino Ratio Rank of BTCY is 5454
Sortino Ratio Rank
The Omega Ratio Rank of BTCY is 5050
Omega Ratio Rank
The Calmar Ratio Rank of BTCY is 1515
Calmar Ratio Rank
The Martin Ratio Rank of BTCY is 2929
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

RES vs. BTCY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for RPC, Inc. (RES) and Biotricity, Inc. (BTCY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current RES Sharpe Ratio is -0.60, which is lower than the BTCY Sharpe Ratio of -0.32. The chart below compares the historical Sharpe Ratios of RES and BTCY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.80-0.60-0.40-0.200.000.20December2025FebruaryMarchAprilMay
-0.60
-0.32
RES
BTCY

Dividends

RES vs. BTCY - Dividend Comparison

RES's dividend yield for the trailing twelve months is around 4.20%, while BTCY has not paid dividends to shareholders.


TTM20242023202220212020201920182017201620152014
RES
RPC, Inc.
4.20%2.69%2.20%0.45%0.00%0.00%2.86%4.76%0.78%0.25%1.30%3.22%
BTCY
Biotricity, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

RES vs. BTCY - Drawdown Comparison

The maximum RES drawdown since its inception was -92.34%, smaller than the maximum BTCY drawdown of -99.67%. Use the drawdown chart below to compare losses from any high point for RES and BTCY. For additional features, visit the drawdowns tool.


-100.00%-95.00%-90.00%-85.00%-80.00%-75.00%-70.00%December2025FebruaryMarchAprilMay
-80.33%
-99.14%
RES
BTCY

Volatility

RES vs. BTCY - Volatility Comparison

The current volatility for RPC, Inc. (RES) is 12.05%, while Biotricity, Inc. (BTCY) has a volatility of 43.26%. This indicates that RES experiences smaller price fluctuations and is considered to be less risky than BTCY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%50.00%60.00%70.00%December2025FebruaryMarchAprilMay
12.05%
43.26%
RES
BTCY

Financials

RES vs. BTCY - Financials Comparison

This section allows you to compare key financial metrics between RPC, Inc. and Biotricity, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00M200.00M300.00M400.00M500.00M20212022202320242025
332.88M
3.62M
(RES) Total Revenue
(BTCY) Total Revenue
Values in USD except per share items

RES vs. BTCY - Profitability Comparison

The chart below illustrates the profitability comparison between RPC, Inc. and Biotricity, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-20.0%0.0%20.0%40.0%60.0%80.0%20212022202320242025
16.0%
76.4%
(RES) Gross Margin
(BTCY) Gross Margin
RES - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, RPC, Inc. reported a gross profit of 53.36M and revenue of 332.88M. Therefore, the gross margin over that period was 16.0%.

BTCY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Biotricity, Inc. reported a gross profit of 2.76M and revenue of 3.62M. Therefore, the gross margin over that period was 76.4%.

RES - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, RPC, Inc. reported an operating income of 12.39M and revenue of 332.88M, resulting in an operating margin of 3.7%.

BTCY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Biotricity, Inc. reported an operating income of -168.98K and revenue of 3.62M, resulting in an operating margin of -4.7%.

RES - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, RPC, Inc. reported a net income of 12.03M and revenue of 332.88M, resulting in a net margin of 3.6%.

BTCY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Biotricity, Inc. reported a net income of -1.23M and revenue of 3.62M, resulting in a net margin of -34.0%.